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Abstract
The timing of DNA synthesis, mitosis and cell division is regulated by a complex network of biochemical reactions that
control the activities of a family of cyclin-dependent kinases. The temporal dynamics of this reaction network is typically
modeled by nonlinear differential equations describing the rates of the component reactions. This approach provides
exquisite details about molecular regulatory processes but is hampered by the need to estimate realistic values for the
many kinetic constants that determine the reaction rates. It is difficult to estimate these kinetic constants from available
experimental data. To avoid this problem, modelers often resort to ‘qualitative’ modeling strategies, such as Boolean
switching networks, but these models describe only the coarsest features of cell cycle regulation. In this paper we describe a
hybrid approach that combines the best features of continuous differential equations and discrete Boolean networks. Cyclin
abundances are tracked by piecewise linear differential equations for cyclin synthesis and degradation. Cyclin synthesis is
regulated by transcription factors whose activities are represented by discrete variables (0 or 1) and likewise for the activities
of the ubiquitin-ligating enzyme complexes that govern cyclin degradation. The discrete variables change according to a
predetermined sequence, with the times between transitions determined in part by cyclin accumulation and degradation
and as well by exponentially distributed random variables. The model is evaluated in terms of flow cytometry
measurements of cyclin proteins in asynchronous populations of human cell lines. The few kinetic constants in the model
are easily estimated from the experimental data. Using this hybrid approach, modelers can quickly create quantitatively
accurate, computational models of protein regulatory networks in cells.
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Introduction
The cell division cycle is the fundamental physiological process
by which cells grow, replicate, and divide into two daughter cells
that receive all the information (genes) and machinery (proteins,
organelles, etc.) necessary to repeat the process under suitable
conditions [1]. This cycle of growth and division underlies all
biological expansion, development and reproduction. It is highly
regulated to promote genetic fidelity and meet the demands of an
organism for new cells. Altered systems of cell cycle control are
root causes of many severe health problems, such as cancer and
birth defects.
In eukaryotic cells, the processes of DNA replication and
nuclear/cell division occur sequentially in distinct phases (S and
M) separated by two gaps (G1 and G2). Mitosis (M phase) is
further subdivided into stages: prophase (chromatin condensation,
spindle formation, and nuclear envelope breakdown), prometa-
phase (chromosome attachment and congression), metaphase
(chromosome residence at the mid-plane of the spindle), anaphase
(sister chromatid separation and movement to opposite poles of the
spindle), telophase (re-formation of the nuclear envelopes), and
cytokinesis (cell division). G1 phase is subdivided into uncommit-
ted and committed sub-phases, often referred to as G1-pm
(postmitotic interval) and G1-ps (pre S phase interval), separated
by the ‘restriction point’ [2]. In this paper, we shall refer to the
sub-phases G1-pm and G1-ps as ‘G1a’ and ‘G1b’ respectively.
Progression through the correct sequence of cell-cycle events is
governed by a set of cyclin-dependent kinases (Cdk’s), whose
activities rise and fall during the cell cycle as determined by a
complex molecular regulatory network. For example, cyclin
synthesis and degradation are controlled, respectively, by tran-
scription factors and ubiquitin-ligating complexes whose activities
are, in turn, regulated by cyclin/Cdk complexes.
Current models of the Cdk control system can be classified as
either continuous or discrete. Continuous models track the
changes of protein concentrations, Cj(t) for j= 1 ,2 ,… ,N,b y
solving a set of nonlinear ordinary differential equations (ODEs) of
the form:
dCj
dt
~
X R
r~1
njrrr C1,C2,:::,CN ðÞ ð 1Þ
where rr is the rate of the r
th reaction and nir is the stoichiometric
coefficient of species i in reaction r. To each rate term is associated
one or more kinetic constants that determine exactly how fast the
reaction proceeds under specific conditions. These kinetic
constants must be estimated from experimental data, and often
there is insufficient kinetic data to determine their values.
Nonetheless, continuous models, based on rate equations, have
been used successfully to account for the properties of cell
proliferation in a variety of cell types: yeast [3,4,5], fruit fly [6],
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also proved successful in predicting novel cell-cycle characteristics
[12,13].
Discrete models, on the contrary, represent the state of each
regulatory protein as Bj(t )=0 or 1 (inactive or active), and the
state variables update from one discrete time step to the next
(t=0, 1, 2, …=ticks of a metronome) according to the rule:
Bj tz1 ðÞ ~Yj B1 t ðÞ , B2 t ðÞ ,...,Bn t ðÞ ðÞ , ð2Þ
where Yj(…) is a Boolean function (i.e., it equates to either 0 or 1)
determined by the topology of the reaction network. For Boolean
networks (BNs) there is no notion of reaction ‘rate’ and, hence, no
need to estimate kinetic constants. BN models of the Cdk
regulatory network have been proposed for yeast cells [14,15]
and for mammalian cells [16]. They have been used to study
notions of ‘robustness’ of the cell cycle, but they have not been
compared in detail to quantitative properties of cell cycle
progression, and they have not been used as predictive tools.
In this paper we propose to combine the strengths of both
continuous and discrete modeling, while avoiding the weaknesses
of each. Our ‘hybrid’ model is inspired by the work of Li et al.
[14], who proposed a BN for cell cycle controls. Their model
employs 11 state variables that move around in a space of
2
11=2048 possible states. Quite remarkably they found that 1764
of these states converge quickly onto a ‘super highway’ of 13
consecutive states that represent a typical cell cycle trajectory
(G1b—S—G2—M—G1a). The results of Li et al. indicate that the
cell cycle control network is ‘robustly designed’ in the sense that
even quite large perturbations away from the usual sequence of
cell cycle states are quickly restored to the super highway. In the
model of Li et al., G1a is a stable steady state; they do not address
the signals that drive cells past the restriction point (the G1a-to-
G1b transition).
Despite their intuitive appeal, Boolean models have severe
limitations. First of all, metronomic time in BN’s is unrelated to
clock time in the laboratory, so Boolean models cannot be
compared to even the most basic observations of time spent by
cells in the four phases of the division cycle [1]. Also, these models
do not incorporate cell size, so they cannot address the evident
importance of cell growth in driving events of the cell cycle
[17,18,19]. Lastly, cyclins are treated as either absent or present
(0 or 1), so Boolean models cannot simulate the continuous
accumulation and removal of cyclin molecules at different stages of
the cell cycle [20].
Our goal is to retain the elegance of the Boolean representation
of the switching network, while introducing continuous variables
for cell size, cell age, and cyclin composition, in order to create a
model that can be compared in quantitative detail to experimental
measurements with a minimal number of kinetic parameters that
must be estimated from the data. To this end, we keep the cyclin
regulators as Boolean variables but model the cyclins themselves as
continuous concentrations that increase and decrease due to
synthesis and degradation. Next, we replace the Boolean model’s
metronome with real clock time to account for realistic rates of
cyclin synthesis and degradation, and for stochastic variability in
the time spent in each Boolean state of the model. Finally, we
introduced a cell size variable, M(t), which affects progression
through late G1 phase. M(t) increases exponentially with time as
the cell grows and decreases by a factor of ,2 when the cell
divides. (The assumption of exponential growth is not crucial;
similar results are obtained assuming linear growth between cell
birth and division.)
Since the pioneering work of Leon Glass [21,22], hybrid
(discrete-continuous) models have been employed by systems
biologists in a variety of forms and contexts [23,24,25]. Engineers
have been modeling hybrid control systems for many years
[26,27,28], and they have created powerful simulation packages
for such systems [29]: SIMULINK [28], SHIFT [30,31] and
CHARON [32], to name a few. We have not used these
simulation packages because our model can be solved analytically.
Results
Hybrid modeling approach
The modeling approach we are proposing is hybrid in two
senses. First, we employ both continuous and discrete variables,
and second we allow for both deterministic and stochastic
processes. Concerning the components of the control system, we
track cyclin levels as continuous concentration variables, but we
use discrete Boolean variables to represent the activities (‘on’ or
‘off’) of the regulatory proteins (transcription factors and
ubiquitinating enzymes) that control cyclin synthesis and degra-
dation. This distinction is equivalent to a presumed ‘separation of
time scales’: the activities of the regulatory proteins change rapidly
between 0 and 1, while the concentrations of cyclins change more
slowly due to synthesis and degradation. The Boolean variables,
we assume, proceed from one state to the next according to a fixed
sequence corresponding roughly to the super highway of Li et al.
[14]. The time spent in each state, however, is not a ‘tick’ of the
metronome but rather the sum of a deterministic execution time
(which may be 0) plus a random, exponentially distributed waiting
time. In this sense, the model combines deterministic and
stochastic processes.
In its present version, our model is not fully autonomous. The
discrete variables do not update according to Boolean functions of
the current state of the network. Rather, they go through a fixed
sequence of states predetermined by the Boolean network model of
Li et al. [14]. The discrete variables determine the rates of
synthesis and degradation of the continuous variables (the cyclins),
and the cyclins feedback on the discrete variables by determining
how much time is spent in some of the Boolean states. This
strategy keeps the model simple and is appropriate for the cases,
considered in this paper, of unperturbed cycling of ‘wild type’ cells,
Author Summary
The physiological behaviors of cells (growth and division,
differentiation, movement, death, etc.) are controlled by
complex networks of interacting genes and proteins, and a
fundamental goal of computational cell biology is to
develop dynamical models of these regulatory networks
that are realistic, accurate and predictive. Historically, these
models have divided along two basic lines: deterministic or
stochastic, and continuous or discrete; with scattered
efforts to develop hybrid approaches that bridge these
divides. Using the cell cycle control system in eukaryotes
as an example, we propose a hybrid approach that
combines a continuous representation of slowly changing
protein concentrations with a discrete representation of
components that switch rapidly between ‘on’ and ‘off’
states, and that combines the deterministic causality of
network interactions with the stochastic uncertainty of
random events. The hybrid approach can be easily tailored
to the available knowledge of control systems, and it
provides both qualitative and quantitative results that can
be compared to experimental data to test the accuracy
and predictive power of the model.
A Hybrid Model of Mammalian Cell Cycle Regulation
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consider more complicated cases, of mutant cells that travel a
different route through discrete state space or of cells that are
perturbed by drugs or radiation, we will have to elaborate on this
basic model with additional rules governing the interactions of the
discrete and continuous variables. We are currently working on
alternative strategies to adapt this basic modeling paradigm to
more complex situations.
Our model (Fig. 1) tracks three cyclin species (A, B and E), two
transcription factors (‘TFE’ and ‘TFB’) and two different E3
ubiquitin-ligase complexes (APC-C and SCF). TFE drives the
synthesis of cyclins E and A early in the cell cycle (comparable to
the E2F family of transcription factors) [33], and TFB drives the
synthesis of cyclins B and A late in the cell cycle (comparable to
FoxM1 and Myc) [34,35]. The Anaphase Promoting Complex—
Cyclosome (APC-C) is active during M phase and early G1, when
it combines with Cdc20 and Cdh1 to label cyclins A and B for
degradation by proteasomes. We make a further distinction
between Cdc20 activity on cyclin A (Cdc20A, active throughout
mitosis) from Cdc20 activity on cyclin B (Cdc20B, activated at
anaphase). The SCF labels cyclin E for degradation via
ubiquitination, but only when cyclin E is phosphorylated [36],
which we assume is correlated primarily with cyclin A/Cdk2
activity [37].
In our model, the two transcription factors and the four
ubiquitination factors are each represented by a Boolean variable,
BTFE, etc. For each cyclin component we write an ordinary
differential equation, d[CycX]/dt=ksx2kdx[CycX], where the
rate ‘constants’ for synthesis and degradation, ksx and kdx, depend
on the Boolean variables (see Table 1). Hence, each cyclin
concentration is governed by a piecewise linear ODE. The
parameters in the model (k
0
sx, ksx
00, etc.) are assigned numerical
values (Table 1), chosen to fit observations of how fast cyclins
accumulate and disappear during different phases of the cell
cycle.
Next, we must assign rules for updating the Boolean variables in
the model. We assume that the Boolean variables follow a strict
sequence of states (see Table 1) that corresponds roughly to the
super highway discovered by Li et al. [14]. This sequence of states
conforms to current ideas of how the mammalian cell cycle is
regulated. Newborn cells are said to be in ‘G1a’ state, because they
are not yet committed to a new round of DNA synthesis and
mitosis. The transcription factors, TFE and TFB, are silent, and
Cdh1/APC-C is active, so the levels of cyclins A, B and E are low
in newborn cells. For a mammalian cell to leave the G1a state and
commit to a new round of DNA replication and division, it must
receive a specific set of extracellular signals (growth factors, matrix
binding factors, etc.), which up-regulate the activity of TFE. We
assume that these ‘proliferation signals’ are present and that our
(simulated) cell spends only a few hours in G1a before transiting
into G1b. In our model, the time spent in G1a is an exponentially
distributed random variable with mean=2 h. When the cell passes
the ‘restriction point’ and enters G1b, TFE is activated and CycE
begins to accumulate. Among other chores, Cdk2/CycE inacti-
vates Cdh1/APC-C, allowing Cdk2/CycA dimers to accumulate.
In our model, the transition from early G1b to late G1b is weakly
size dependent, because the condition for this transition is that
[CycE]*Mass exceeds a certain threshold (hE). Because this
transition depends on cell mass, those cells that are larger than
average tend to make the transition sooner, and cells that are
smaller than average tend to make the transition later. This effect
allows the cell population to achieve a stable size distribution. In
the late G1b state, CycA/Cdk2 level rises to a certain threshold
(hA), when it triggers entry into S phase. Cdk2/CycA also
promotes the degradation of cyclin E by SCF during S phase. We
assume that DNA synthesis requires at least 7 h.
Cyclin B begins to accumulate in late G1 and S, after Cdh1 is
inactivated, but the major accumulation of cyclin B protein occurs
in G2 phase, after DNA synthesis is completed and TFB is
activated. The G2—M transition is delayed until enough Cdk1/
CycB dimer accumulates ([CycB].hB9) to promote entry into
prophase and the appearance Cdc20A/APC-C, which begins the
process of cyclin A degradation [38,39,40]. Cdc20B/APC-C is
activated at the metaphase—anaphase transition, where it
promotes three crucial tasks: (1) separation of sister chromatids
by the mitotic spindle, (2) partial degradation of cyclin B, and (3)
re-activation of Cdh1. Cdh1/APC-C degrades Cdc20 [41], and
then finishes the job of cyclin B degradation (telophase). When
[CycB] drops below the threshold hB0, the cell finishes telophase
and divides into two newborn daughter cells in G1 phase
(unreplicated chromosomes) with low levels of cyclins A, B and E.
We assume that cell division is symmetric, with some variability;
i.e., the mass of the two daughter cells at birth are dMdiv and
(12d)Mdiv, where Mdiv=mass of mother cell at division, and d is a
Gaussian-distributed random variable with mean=0.5 and
standard deviation=0.0167. In all simulations reported here we
assume that cells grow exponentially between birth and division.
However, we have also simulated linear growth, and the results are
not significantly different.
We introduce stochastic effects into the model by assuming that
the time spent in each state of the Boolean subsystem, as it moves
along the super highway, has a random component (Tr
i ) as well as
a deterministic component (Td
i ): Ti~Td
i zTr
i . From Table 1, we
see that Td
i ~0 for i=1 ,6 ,7 ,8 ,a n dTd
4~7 h. For the remaining
cases (i= 2 ,3 ,5 ,9 ) ,Td
i is however long it takes for the cyclin
variable to reach its threshold. The stochastic component for each
transition is a random number chosen from an exponential
distribution with mean=li. The random time delay is calculated
from a uniform random deviate, r, by the formula Tr
i ={li ln(r).
The values chosen for the li’s are given in Table 1.
In the Methods section, we describe how we simulate the
progression of a single cell through its DNA replication/division
cycle. Because the model’s differential equations are piecewise
linear, they can be solved analytically, and an entire ‘cell cycle
trajectory’ can be determined by computing a few random
numbers and solving some algebraic equations. A typical result of
such simulations, over three cell cycles, is illustrated in Fig. 1B. Not
surprisingly, the accumulation and loss of the cyclins correlate with
the activities of the cyclin regulators. At the beginning of each
cycle, the cell starts in State 1 (G1a phase in Table 1), with low
levels of all cyclin because TFE and TFB are off and Cdh1 is on.
When the cell leaves G1a, TFE turns on and cyclin E rises rapidly,
but cyclin A increases only modestly, because Cdh1 is still active in
early G1b. Cdh1 turns off when cyclin E level crosses hE, allowing
cyclin A to increase dramatically in late G1b and drive the cell into
S phase (State 4). Cyclin B increases modestly in late G1 and S
phase, because Cdh1 is off but TFB has not yet turned on. Cyclin
E is degraded in S phase, because SCF is now active. When the
cell finishes DNA synthesis, TFB turns on, causing further increase
of cyclins A and B. When cyclin B level rises above its first
threshold, hB9, the cell enters prophase (State 6) and then
prometaphase-metaphase (State 7). During State 7, cyclin A level
drops precipitously because Cdc20A is turned on. After the
replicated chromosomes are fully aligned on the mitotic spindle,
Cdc20B turns on (State 8) and cyclin B is partially degraded.
Cdc20B activates Cdh1 (State 9) and cyclin B is degraded even
faster. When cyclin B level drops below its second threshold, hB0,
the cell divides and returns to G1a (State 1).
A Hybrid Model of Mammalian Cell Cycle Regulation
PLoS Computational Biology | www.ploscompbiol.org 3 February 2011 | Volume 7 | Issue 2 | e1001077Figure 1. The model. (A) The synthesis and degradation of cyclin proteins is regulated by transcription factors (TFE and TFB) and by ubiquitination
machinery (SCF, Cdc20 and Cdh1). (B) Three successive cell cycles are simulated as explained in the Methods. Upper panel: gray curve, 30?M(t); blue
curve, [CycE]?M(t); thegoldline andthepink line indicate the time periods when TFE=1 andSCF=1, respectively. Lower panel: greencurve, [CycA]?M(t);
red curve, [CycB]?M(t); the colored bars indicate the time periods when the Boolean variables are active, according to the legend in the inset.
doi:10.1371/journal.pcbi.1001077.g001
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Our first test for the hybrid model is to simulate flow cytometry
measurements of the DNA content and cyclin levels in an
asynchronous population of RKO (colon carcinoma) cells [42]. In
the data set, a typical scatter plot has about 65000 data points,
each point displaying the measurements of two observables in a
single cell chosen at random from the cell cycle (Fig. 2). When the
data are plotted in this way, they form a cloudy tube of points
through a projection of the state space (say, cyclin B versus cyclin
A). Because there will be some cells from every phase of the cell
cycle, the tube closes on itself. If the system were completely
deterministic and the measurements were absolutely precise, the
data points would be a simple closed curve (a ‘limit cycle’) in the
state space. The data actually present a fuzzy trajectory that snakes
through state space before closing on itself. The indeterminacy of
the points comes (presumably) from two sources: intrinsic noise in
the molecular regulatory system (modeled by the random waiting
times, Tr
i ) and extrinsic measurement errors, which we shall
introduce momentarily. Our strategy for simulating flow-cytom-
etry data is explained in more detail in the Methods section.
In Fig. 2 we compare our simulated flow-cytometry scatter plots
with experimental results of Yan et al. [42]. We color-code each
cell in the simulated plot according to which Boolean State
(Table 1) the cell is in at the time of fixation. In Fig. 3 we plot
cyclin E fluctuations, as predicted by our model, along with a
projection of the cell cycle trajectory in a subspace spanned by the
three cyclin variables (A, B and E).
Contact inhibition of cultured cells
As a further test of the utility of this modeling approach, we
have used our hybrid model to simulate an exponentially growing
population of an immortalized Human Umbilical Vein Endothe-
lial cell line (HUVEC). In the experiment (Fig. 4A; see Methods), a
culture is seeded with 5610
4 cells on ‘Day 0’ and allowed to grow.
At Day 6, it reaches confluence and cell number plateaued at a
constant level.
To apply the hybrid model to this data, we had to devise a way
to model contact inhibition, which arrests cells in a stable
quiescent state. To this end, we assume that the transition
probability, p, for exiting State 1 is a function of the number of
cells alive at that time, N:
p~
p0
1zexp
N{N0
N1
   : ð3Þ
For 0,N1%N0, p is a sigmoidal function of N that drops abruptly
from p0 to 0 for N.N0. For each cell in this simulation, we set l1
(the mean for the random time spent in G1a) to 1/p, and we
choose p0=0.5 h
21 to conform to the value of l1 in Table 1. As
the population size N increases, the time spent in G1a phase
increases until cells eventually arrest in State 1, and the growth
curve, N(t), levels off. In this case, State 1 in our model corresponds
to a quiescent state (G0) in which cells are alive but not
proliferating.
To make the simulation more tractable, we start off with 500
cells (instead of 50,000 cells) and follow the lineage of each initial
cell until Day 10. Every 24 hours, we compute the number of cells
alive at that point of time and plot the results in Fig. 4A, along with
the experimental data (scaled down by a factor of 100). The
parameter values, N0=11,000 and N1=500, are chosen to fit the
simulation to the observed growth curve. From the model we can
also compute the percentage of cells in G0/G1, S and G2/M
phases on each day (Fig. 4C), and the results compare favorably
Table 1. Hybrid model of mammalian cell cycle control.
d CycA ½ 
dt ~ksa{kda½CycA  ksa~k0
sazk00
saBTFEzk000
saBTFB k0
sa~5 k00
sa~6 k000
sa~20
kda~k0
dazk00
daBCdc20Azk000
daBCdh1 k0
da~0:2 k00
da~1:2 k000
da~1:2
d½CycB 
dt ~ksb{kdb½CycB  ksb~k0
sbzk
00
sbBTFB k0
sb~2:5 k
00
sb~6
kdb~k0
dbzk00
dbBCdc20Bzk000
dbBCdh1 k0
db~0:2 k
00
db~1:2 k000
db~0:3
d½CycE 
dt ~kse{kde½CycE 
kse~k0
sezk00
seBTFEkse~k0
sezk00
seBTFE k0
se~0:02 k00
se~2
kde~k0
dezk00
deBSCF k0
se~0:02 k00
de~0:5
dM
dt ~c:M M~d:M at division c~0:029 hr{1 d~0:5:G
a
G : m~1,s~3:33
State Phase BTFE BSCF BTFB BCdc20A BCdc20B BCdh1 Condition for exit l (h)
1 G 1 a 000001none 2
2 Early G1b 100001[ C y c E ] * M=hE 0
3 Late G1b 1 0 0 0 0 [CycA].hA 0.01
4 S 110000Tmin=7h 1
5 G 2 111000[ C y c B ] .h0
B 0.5
6 P r o p h a e 011000none 0.75
7 M e t a p h a s e 011100none 1.5
8 A n a p h a s e 011110none 0.5
9 T e l o p h a s e 010111[CycB],h
00
B 0.025
aG is a Gaussian random variable with mean=1, s=3.3%.
hA =12.5, h0
B =21.25, h
00
B =3,hE =80.
doi:10.1371/journal.pcbi.1001077.t001
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simulate the patterns of cyclin A2 and cyclin B1 expression on
each day for the growing population of HUVEC cells (see
Supporting Fig. S1).
Discussion
We have constructed a simple, effective model of the cyclin-
dependent kinase control system in mammalian cells and used the
model to simulate faithfully the accumulation and degradation of
cyclin proteins during asynchronous proliferation of RKO (colon
carcinoma) cells. The model is inspired by the work of Li et al.
[14], who proposed a robust Boolean model of cell cycle regulation
in budding yeast. Our goal was to retain the elegance of the
Boolean representation of the switching network, while introduc-
ing continuous variables for cell size, cell age, and cyclin
composition, in order to create a model that could be compared
in quantitative detail to experimental measurements.
We have shown that this model can accurately simulate flow-
cytometric measurements of cyclin abundances in asynchronous
populations of growing-dividing mammalian cells. The parameters
in the model that allow for a quantitative description of the
experimental measurements are easily estimated from the data
itself. Now that the model is parameterized and validated for wild-
type cells, we are currently extending it to handle the behavior of
cell populations perturbed by drugs and by genetic interference. In
some cases, only modest extensions of the model are required; in
other cases, a more thorough overhaul of the way the discrete and
continuous variables interact with each other is necessary.
We have chosen parameter values in our model to capture the
major features of cyclin fluctuations as measured by flow
cytometry during the somatic division cycle of mammalian cells.
We have used a human tumor cell line to calibrate our model.
Between cell lines and normal human cultured cells, there are
differences in the expressions of A and B cyclins [43]; however,
when the levels of cyclin B1 were rigorously compared for HeLa,
K562, and RKO cells, both the patterns and magnitudes of
expression are remarkably similar, apparently dependent to some
degree on the rate of population growth [44]. In addition, the
patterns of expression of cyclins A2 and B1 are similar for these
human tumor cell lines and stimulated normal human circulating
lymphocytes (Supporting Fig. S2). Overall, the simulation outputs
have satisfying similarity both in pattern and magnitude to the real
data for RKO cells, and our simulated expression patterns of
cyclins A, B and E for the tumor cell line are quite similar to the
simulated expression patterns in HUVEC cells (see Supporting
Fig. S1).
However, there remain some inconsistencies between our
mathematical simulations and our experimental observations that
point out where future modifications to the model are needed. For
example, in the model DNA synthesis starts when cyclin A has
accumulated to ,8% of its maximum level (see arrow in Fig. 2D;
50/600<8%), whereas in our measurements DNA synthesis starts
when cyclin A is ,5% of its maximum level (arrow in Fig. 2C).
This discrepancy is tempered by the fact that we are not confident
of the quantitative accuracy of cyclin A expression levels below
,4% of its maximum level in Fig. 2C. Where we place the
minimum expression level of cyclin A in Fig. 2D affects our
estimate of the cyclin A level at onset of DNA synthesis (50 AU at
present). By lowering the minimum expression level of cyclin A
below 10 AU in Fig. 2D (e.g., by lowering k9sa), we could line up
the two arrows in Figs. 2C and D. Nonetheless, we observe
(Supporting Fig. S3) that cyclin A expression correlates highly with
Figure 2. Scatter plots. (A,C,E) Flow cytometry data from Yan et al [42]. DNA=190 corresponds to G1 and DNA=380 corresponds to G2/M. (B,D,F)
Our simulations. We are plotting the total amount of cyclin A and cyclin B per cell, i.e., [CycA]?M(t) and [CycB]?M(t). DNA=1 in G0/G1 phase; =2 in G2/
M phase. Some ‘instrumental noise’ has been added to the calculated levels of cyclins and DNA, as described in the Methods. The arrows in (A, B)
indicate the rate of cyclin B accumulation in S phase in the measurements and in the model. The arrows in (C, D) indicate the cyclin A level at the
onset of DNA synthesis, compared to the maximum expression level of ,600 AU.
doi:10.1371/journal.pcbi.1001077.g002
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cyclin A begins simultaneously with the onset of DNA synthesis,
whereas in our model cyclin A production begins in mid-G1
phase. This discrepancy could be minimized by lowering the
cyclin A threshold (hA) in the model.
The simulation (Fig. 2B) captures the observed accummulation
of cyclin B in late G1 (when Cdh1 turns off), but the simulated rise
in cyclin B during S phase appears to be faster than the observed
rise [45] (compare the arrows in Figs. 2A and B). The simulation
does capture the rapid accumulation of cyclin B observed in G2.
Finally, while we did not calibrate the cyclin E expression
parameters to any specific dataset, the pattern of expression in
Fig. 3A is quite similar to expected expression patterns for normal
human somatic cells and some human tumor cell lines [46].
We believe that our hybrid approach will be generally useful for
modeling macromolecular regulatory networks in cells, because it
combines the qualitative appeal of Boolean models with the
quantitative realism of reaction kinetic models.
Methods
Simulations
We simulate a flow cytometry experiment with our hybrid
model in two steps.
Step 1: Creating complete ‘life histories’ for thousands of cells. At the start
of the simulation, we specify initial conditions at the beginning of
the cycle (State 1) for a progenitor cell. We used the following
initial values of the state variables: [CycA]=[CycB]=[CycE]=1
and M=3. Our strategy is to follow this cell through its cycle until
it divides into two daughters. We then choose one of the two
daughters at random and repeat the process, continuing for 32500
iterations. We discard the first 500 cells, and keep a sample of
Figure 3. Model predictions of cyclin E dynamics. (A) Scatter plots. (B) Stochastic limit cycle in the state space of cyclins A, B and E. We provide
two different perspectives of this three dimensional figure to help visualize how the cyclin levels go up and down. In addition, we have added
golden-colored balls to help guide the eye along the cell cycle trajectory. Each ball represents the average of the cyclin levels of all the cells binned
over a hundredth of the Qi interval [0,1], where Qi refers to the fraction of the cell cycle completed by cell i (as described in the Methods section).
Finally, it may help to recognize that Fig. 2E is a projection of the data on the CycA-CycB plane, and Fig. 3B is a projection on the CycA-CycE plane.
doi:10.1371/journal.pcbi.1001077.g003
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according to our model. In the second step, we create a simulated
sample of 32000 cells chosen at random phases of the cell cycle, to
represent the cells that were assayed by the flow cytometer.
Let us consider cell i (1,i,32500) at the time of its birth, ti0.B y
definition, this cell is in State 1, and we assume that we know its
birth mass, M(ti0), and its starting concentrations of cyclins A, B
and E. Denote the starting concentrations as [CycA(ti0)],
[CycB(ti0)], [CycE(ti0)]. In the ensuing discussion, unless it is
necessary for clarity, we drop the i subscript, it being understood
that we are talking about a representative cell in the population.
We will follow this cell until it divides to produce a daughter cell
with known concentrations of cyclins.
According to Table 1, a cell in State 1 has no special conditions to
satisfybefore moving to State 2. Hence the residence time in State 1 is a
random number Tr
1 chosen from an exponential distribution with
mean l1=2 h. The cell enters State 2 at t1=t0+Tr
1. Assuming
exponential growth, its size at this time is M(t1)=M(t0)
exp{c(t12t0)}=M(t0)e x p { cA1}, where c is the specific growth rate of
the culture and A1=t12t0 is the age of the cell when it exits State 1. To
illustrate how cyclin concentrations are computed at t=t1,l e tu s
consider cyclin A as an example. During the interval t0,t,t1,[ C y c A ]
satisfies a linear ODE with effective rate constants ksa1=k9sa=5and
kda1=k9da+k09da=1.4, because BTFE=BTFB=BCdc20A=0 and
BCdh1=1 for a cell in State 1. We can compute the concentration of
cyclin A at any time during this interval from
½CycA(t) ~
ksa1
kda1
z CycA(t0) ½  {
ksa1
kda1
  
e{kda1(t{t0),toƒtƒt1 ð4Þ
Setting t=t1 in this equation gives the number we seek. In this fashion,
we start tabulating the following information for each simulated cell:
Time t0 t1 t2 ...
Enter State 1 2 3 ...
Age 0 A1~t1{t0 A2~t2{t0
Size Mt 0 ðÞ Mt 1 ðÞ Mt 2 ðÞ ...
Cyclin A CycA t0 ðÞ ½  CycA t1 ðÞ ½  CycA t2 ðÞ ½  ...
Cyclin B CycB t0 ðÞ ½  CycB t1 ðÞ ½  CycB t2 ðÞ ½  ...
Cyclin E CycE t0 ðÞ ½  CycE t1 ðÞ ½  CycE t2 ðÞ ½  ...
Notice that, at t=t1 when the cell enters State 2, the
transcription factor (TFE) for cyclins E and A turns on, and these
cyclins start to accumulate. The cell cannot leave State 2 until
cyclin E accumulates to a sufficiently high level: [Cy-
cE](t)?M(t)=hE, according to Table 1. When this condition is
satisfied, the cell leaves State 2 and enters State 3. The size
dependence on this transition is a way to couple cell growth to the
DNA replication-division cycle. According to the parameter
settings in Table 1, there is no stochastic component to the
transition out of State 2.
We continue in this fashion until the cell leaves State 9 and
returns to State 1, when cyclin B is degraded at the end of mitosis.
This is the signal for cell division. The age of the cell at division is
A9=t92t0, and the mass of the cell at division is M(t9)=M(t0)
exp(c?A9). The mass of the daughter cell at the beginning of her life
history is Mdaughter(t0)=d?Mmother(t9), where d is a random number
sampled from a normal distribution of mean 0.5 and standard
deviation 0.0167 to allow for asymmetries of cell division.
Notice that simulating the life history of a single cell only
requires generating about a dozen random numbers and
performing a handful of algebraic calculations. At no point do
we need to solve differential equations numerically. Hence we can
quickly calculate the life histories of tens of thousands of cells.
Step 2: Finding the DNA and cyclin levels of each cell in an asynchronous
sample. In the flow cytometry experiments of Yan et al. [42], a
random sample of cells is taken from an asynchronous population,
the cells are fixed and stained, and then run one-by-one through
laser beams where fluorescence measurements are made. So each
data point consists of measurements of light scatter (related to cell
size) and fluorescence proportional to DNA and cyclin content for
a single cell taken at some random point in the cell cycle. To
simulate this experiment we must assign to each of our 32000
simulated cells a number Qi selected randomly from the interval
[0,1], where Qi refers to the fraction of the cell cycle completed by
cell i when it was fixed and stained for measurement. Because each
mother cell divides into two daughter cells, the density of cells at
birth, Q=0, is twice the density of cells at division, Q=1. The
‘ideal’ probability density for an asynchronous population of cells
expanding exponentially in number is
f(Q)~(ln2):21{Q ð5Þ
According to the ‘transformation method’ [47, Chapter 7.2], we
compute Q as
Figure 4. Contact inhibition of a culture of human umbilical vein endothelial cells. (A) Growth curve for the HUVEC population over 10
days, showing the base-10 logarithm of the cell count for both experimental data and our simulation (with N0=11000 and N1=500). (B) Daily
distribution of cells across the phases of the cell cycle, from experimental data. (C) Model simulation of the phase distributions.
doi:10.1371/journal.pcbi.1001077.g004
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2
2{r
  
ð6Þ
where r is a random number chosen from a uniform distribution
on [0,1]. In this way, we generate 32000 fractions, Qi.
If Qi is the cell-cycle location of the i
th cell when it is selected for
the flow cytometry measurements, then its age at the time of
selection is ai=Qi?Ai9, where Ai9 is the age of the i
th cell at division.
Given a value for ai, we then find the state n (=1, 2, … or 9) of the
i
th cell at the time of its selection:
ti,n{1ƒti0zaivti,n ð7Þ
where ti,n (as defined above) is the time at which the i
th cell left state
n to enter state n+1.
Once we know the state n of the cell, we can compute the
concentration of each cyclin in the cell at its exact age ai by
analogy to Eq. [4]:
½CycA(ai) ~
ksa,n
kda,n
z CycA(ti,n{1) ½  {
ksa,n
kda,n
  
e
{kda,n(ti0zai{ti,n{1) ð8Þ
where ksa,n and kda,n are the synthesis and degradation rate
constants for cyclin A in state n. This is a straightforward
calculation because in Step 1 we stored the values of tn and
[CycA(tn)] for every state of each cell. We can also calculate the
mass of cell i at the time of its selection:
M(ai)~M(ti0):exp(c:ai) ð9Þ
where M(ti0) is the mass at birth of cell i and c is the specific growth
rate of the culture. Because the flow cytometer measures the total
amount of fluorescence proportional to all cyclin A molecules in
the i
th cell, we take as our measurable the product of [CycA(ai)]
times M(ai).
Lastly we determine the DNA content of cell i at age ai
according to:
DNA=1 for ti0#ti0+ai,ti3=entry of i
th cell into S phase
DNA=1+(ti0+ai2ti3)/(ti42ti3) for ti3#ti0+ai,ti4=exit of
i
th cell from S phase
DNA=2 for ti4#ti0+ai,ti9
Now we have simulated values for the measurable quantities of
each cell at the time point in the cell cycle when it was selected for
analysis. Before plotting these numbers, we should take into
account experimental errors, such as probe quality, fixation,
staining and measurement. We do so by multiplying each
measurable quantity (DNA content and cyclin levels) by a random
number chosen from a Gaussian distribution with mean 1 and
standard deviation=0.03 for DNA measurements and 0.15 for
cyclin measurements. These choices give scatter to the simulated
data that is comparable to the scatter in the experimental data.
Source codes for the hybrid model are provided in the
Supporting Text S1.
Cells, culture, and fixation
Culture and fixation of RKO cells were described in [42]. The
immortalized HUVEC cells [48] at passage 93 were seeded at
2.5610
3 cells/cm
2 in 10 ml EGM-2 media with 2% fetal bovine
serum (Lonza, Basel). Duplicate plates were prepared for each
time point at days 1, 2, 3, 4, 5, 6, 7, 10, and 15. Cells were fed
every other day by replacing half the volume of used media. At the
indicated times, cells were trypsinized, washed, and cell counts
performed with a Guava Personal Cytometer (Millipore, Billerica,
MA). Fixation was as previously described [49]; briefly, cells were
treated with 0.125% formaldehyde (Polysciences, Warrington, PA)
for 10 min at 37uC, washed, then dehydrated with 90% Methanol.
Cells were fixed in aliquots of 1610
6 cells (days 1–3) or 2610
6
(days 4–15). Fixed cell samples were stored at 220uC until staining
for cytometry.
Immunofluorescence staining, antibodies, flow
cytometry
Staining and cytometry for RKO cells were described in [42].
Briefly, cells were trypsinized, fixed with 90% MeOH, washed
with phosphate buffered saline, then stained with monoclonal
antibodies reactive with cyclin B1, cyclin A, phospho-S10-histone
H3, and with 49,6-diamidino-2-phenylindole (DAPI). For a
detailed, updated version of antibodies, staining, and cytometry
for cyclins A2 and B1, phospho-S10-histone H3, and DNA
content, see Jacobberger et al. (38).
Data pre-processing
Data pre-processing was performed with WinList (Verity
Software House, Topsham, ME). Doublet discrimination (peak
versus area DAPI plot) was used to limit the analysis to singlet cells;
non-specific binding was used to remove background fluorescence
from the total fluorescence related to cyclin A2 and B1 staining.
The phycoerythrin channel (cyclin A2) was compensated for
spectral overlap from FITC or Alexa Fluor 488. For simplification,
very large 2C G1 HUVEC cells and any cells cycling at 4CR8C
were removed from the analysis. These were present at low
frequency. Data were written as text files then transferred to
Microsoft Excel.
Supporting Information
Figure S1 Patterns of Cyclin A and Cyclin B expression in
simulated populations of HUVECs growing toward confluence
over days 0–10.
Found at: doi:10.1371/journal.pcbi.1001077.s001 (0.75 MB PDF)
Figure S2 Pattern of Cyclin A expression in stimulated human
circulating lymphocytes.
Found at: doi:10.1371/journal.pcbi.1001077.s002 (0.05 MB PDF)
Figure S3 Correlation of Cyclin A expression with BrdU
labeling.
Found at: doi:10.1371/journal.pcbi.1001077.s003 (0.33 MB PDF)
Text S1 Source codes.
Found at: doi:10.1371/journal.pcbi.1001077.s004 (0.18 MB
DOC)
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